Liisa Sailas

Papers

Total Citations

H-Index

About

Liisa Sailas is a leading clinical researcher in radiation oncology, with a focused expertise in stereotactic body radiotherapy (SBRT) for prostate cancer. Her work has been instrumental in advancing hypofractionated treatment protocols, demonstrating that high-dose-per-fraction SBRT is both safe and effective for localized prostate cancer—a paradigm shift supported by the low α/β-ratio of prostate tumors. Her most-cited paper, "Hypofractionated stereotactic body radiotherapy for localized prostate cancer – first Nordic clinical experience" (2017, 26 citations), provides critical real-world data from the Nordic region, establishing a benchmark for clinical adoption. Complementing this, her dosimetric comparison study (2016, 25 citations) systematically evaluated four SBRT techniques, offering essential guidance on treatment planning and delivery efficiency. Through these contributions, Sailas has directly shaped modern prostate cancer radiotherapy, bridging technical innovation with clinical practice. Her research is widely cited by peers seeking evidence-based protocols for SBRT implementation, cementing her reputation as a key figure in Nordic radiation oncology and a valuable resource for students and clinicians exploring high-precision cancer treatments.